Shares of Johnson & Johnson (NYSE: JNJ) were sliding today as the diversified healthcare company edged past estimates in its fourth-quarter earnings report, but agreed to pay $700 million to settle lawsuits saying that its talc-based baby powder caused cancer.

J&J also announced a settlement with the state of Washington over opioid-related claims for $149.5 million and said it had now resolved all pending litigation over the opioid crisis.

As of 11:08 a.m. ET, the stock was down 2%.

Continue reading

Source Fool.com